Florida 2025 2025 Regular Session

Florida House Bill H1089 Comm Sub / Bill

Filed 04/01/2025

                       
 
CS/HB 1089  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1089-01-c1 
Page 1 of 2 
F L O R I D A H O U S E O F R E P R E S E N T A	T I V E S 
 
 
 
A bill to be entitled 1 
An act relating to newborn screenings; amending s. 2 
383.14, F.S.; beginning on a specified date, subject 3 
to appropriation, requiring that the Department of 4 
Health's rules require that newborns be screened for 5 
Duchenne muscular dystrophy at the appropriate age; 6 
providing an effective date. 7 
 8 
Be It Enacted by the Legislature of the State of Florida: 9 
 10 
 Section 1.  Paragraph (a) of subsection (2) of section 11 
383.14, Florida Statutes, is amended to read: 12 
 383.14  Screening for metabolic disorders, other hereditary 13 
and congenital disorders, and environmental risk factors. — 14 
 (2)  RULES.— 15 
 (a)  After consultation with the Genetics and Newborn 16 
Screening Advisory Co uncil, the department shall adopt and 17 
enforce rules requiring that every newborn in this state shall: 18 
 1.  Before becoming 1 week of age, have a blood specimen 19 
collected for newborn screenings; 20 
 2.  Be tested for any condition included on the federal 21 
Recommended Uniform Screening Panel which the council advises 22 
the department should be included under the state's screening 23 
program. After the council recommends that a condition be 24 
included, the department shall submit a legislative budget 25     
 
CS/HB 1089  	2025 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb1089-01-c1 
Page 2 of 2 
F L O R I D A H O U S E O F R E P R E S E N T A	T I V E S 
 
 
 
request to seek an a ppropriation to add testing of the condition 26 
to the newborn screening program. The department shall expand 27 
statewide screening of newborns to include screening for such 28 
conditions within 18 months after the council renders such 29 
advice, if a test approved b y the United States Food and Drug 30 
Administration or a test offered by an alternative vendor is 31 
available. If such a test is not available within 18 months 32 
after the council makes its recommendation, the department shall 33 
implement such screening as soon as a test offered by the United 34 
States Food and Drug Administration or by an alternative vendor 35 
is available; and 36 
 3.  At the appropriate age, be tested for such other 37 
metabolic diseases and hereditary or congenital disorders as the 38 
department may deem necess ary. Subject to legislative 39 
appropriation, beginning January 1, 2027, the rules must require 40 
that newborns be screened for Duchenne muscular dystrophy at the 41 
appropriate age. 42 
 Section 2. This act shall take effect July 1, 2025. 43